How many and who are patients with heart failure eligible to SGLT2 inhibitors? Responses from the combination of administrative healthcare and primary care databases.
- Autori: Piccinni C, Dondi L, Calabria S, Ronconi G, Pedrini A, Lapi F, Marconi E, Parretti D, Medea G, Cricelli C, Martini N, Maggioni AP.
- Titolo: How many and who are patients with heart failure eligible to SGLT2 inhibitors? Responses from the combination of administrative healthcare and primary care databases.
- Rivista: Int J Cardiol. 2022 Sep 26:S0167-5273(22)01403-6. doi: 10.1016/j.ijcard.2022.09.053.
- Link pubblicazione
Esprimi il gradimento a questo contenuto
[Totale voti: 1 Media: 5]
